Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (171-180 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Gastroenterology & Hepatology|April 27, 2021
Implementing capnography to help improve patient safety during procedural sedation: quality improvement in a high-volume gastroenterology departmentRaf Bisschops, Rhodri Saunders, Christophe Dooms, et al.
Inflammatory Bowel Diseases|September 19, 2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel DiseasesZhe Li, Séverine Vermeire, Dominique Bullens, et al.
Frontiers in Immunology|January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
The American Journal of Gastroenterology|February 20, 2003
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's diseaseGert Van Assche, Dirk Vanbeckevoort, Didier Bielen, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 9, 2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel DiseaseMaaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, et al.
International Journal of Inflammation|December 23, 2011
Assessment of the microbiota in microdissected tissues of Crohn's disease patientsGert De Hertogh, Bart Lemmens, Peter Verhasselt, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
The American Journal of Gastroenterology|November 14, 2012
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healingTalat Bessissow, Bart Lemmens, Marc Ferrante, et al.
Scientific Reports|July 13, 2019
Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13Brecht Creyns, Jonathan Cremer, Tomoaki Hoshino, et al.
Pageof 29

Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Gastroenterology & Hepatology|April 27, 2021
Implementing capnography to help improve patient safety during procedural sedation: quality improvement in a high-volume gastroenterology departmentRaf Bisschops, Rhodri Saunders, Christophe Dooms, et al.
Inflammatory Bowel Diseases|September 19, 2015
Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel DiseasesZhe Li, Séverine Vermeire, Dominique Bullens, et al.
Frontiers in Immunology|January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseBram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
The American Journal of Gastroenterology|February 20, 2003
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's diseaseGert Van Assche, Dirk Vanbeckevoort, Didier Bielen, et al.
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 9, 2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel DiseaseMaaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, et al.
International Journal of Inflammation|December 23, 2011
Assessment of the microbiota in microdissected tissues of Crohn's disease patientsGert De Hertogh, Bart Lemmens, Peter Verhasselt, et al.
Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.
The American Journal of Gastroenterology|November 14, 2012
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healingTalat Bessissow, Bart Lemmens, Marc Ferrante, et al.
Scientific Reports|July 13, 2019
Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13Brecht Creyns, Jonathan Cremer, Tomoaki Hoshino, et al.
Pageof 29